持续释放的微针贴片用于显著的多克萨佐甲酸系统输送
Imran Anwar1, Nadiah Zafar2, Asif Mahmood3
1Faculty of Pharmacy, The University Lahore, Lahore, Pakistan.
BioImpacts : BI
|March 31, 2025
概括
这项研究开发了一种用于持续药物输送的新型微针贴片,与传统药片相比,它显示出更好的药理学特征和生物相容性. 微针贴片为增强治疗疗效提供了一个有希望的替代方案.
科学领域:
- 制药科学 制药科学
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
背景情况:
- 微针贴片提供了一种微侵袭的方法,用于通过皮肤递送药物.
- 多克萨佐甲基酸是一种治疗剂,通常是口服的,面临生物可用性挑战.
- 控制药物释放对于优化治疗结果和减少副作用至关重要.
研究的目的:
- 为了制造和描述含有多克萨佐辛甲酸盐的持续释放微针贴片.
- 评估皮肤透,活体药物释放和开发的微针贴片的药理学特性.
- 为了比较微针贴片的性能与商业上可用的多克萨佐辛甲酸片.
主要方法:
- 微针贴片是通过溶剂造使用奇托和聚乙烯醇制备的.
- 鉴定包括显微镜评估,机械强度测试,药物加载和FTIR光谱.
- 使用猪耳皮进行了ex-vivo皮肤透,释放研究和药理动力学评估.
主要成果:
- 优化的微针贴片 (SRF-6) 显示了尖的针尖 (600μm高) 和高药物负载 (92.11%).
- 贴片表现出良好的机械强度 (1.94N),并在48小时内释放了87.24%的多克萨佐甲基酸盐.
- 与口服药片相比,包括AUC和Cmax在内的药理动力学参数显著改善,具有验证的生物相容性.
结论:
- 成功制造的微针贴片可确保有效的药物透和受控的释放.
- 开发的微针贴片系统显示出提供具有生物可用性问题的治疗药物的潜力.
- 这项技术为口服提供了有效的替代品,克服了第一通代谢的限制.
相关概念视频
Drug Delivery: Miscellaneous Routes
286
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
286
Drug Delivery: Enteral Route
350
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
350
Drug Delivery: Parenteral Route
341
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
341
Drug Delivery: Overview
260
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
260
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
421
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
421


